1. Home
  2. GAIA vs PLRX Comparison

GAIA vs PLRX Comparison

Compare GAIA & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

N/A

Current Price

$1.89

Market Cap

70.9M

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

68.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
PLRX
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
68.7M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
GAIA
PLRX
Price
$1.89
$1.08
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$6.50
$2.67
AVG Volume (30 Days)
116.7K
694.7K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
29.97
EPS
N/A
N/A
Revenue
$4,500,000.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$12.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.50
N/A
52 Week Low
$1.82
$1.05
52 Week High
$6.39
$1.95

Technical Indicators

Market Signals
Indicator
GAIA
PLRX
Relative Strength Index (RSI) 35.31 41.60
Support Level N/A N/A
Resistance Level $2.19 $1.37
Average True Range (ATR) 0.10 0.05
MACD -0.01 -0.00
Stochastic Oscillator 22.67 24.00

Price Performance

Historical Comparison
GAIA
PLRX

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: